AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16007327 — intervention group
Group type: EXPERIMENTAL
Intervention: All monthly regimens
Number of subjects: 1609
Study 16007327 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg and 150 mg monthly regimens
Number of subjects: 1609
Study 16007327 — intervention group
Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 1609
Study 12910557 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs (specifically indomethacin, meclofenamate, piroxicam)
Number of subjects: 55
Study 12910557 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosages of NSAIDs
Number of subjects: 55
Study 12910557 — intervention group
Group type: EXPERIMENTAL
Intervention: Other NSAIDs (regardless of dosage)
Number of subjects: 55
Study 12910557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 11776606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasea
Number of subjects: 98
Study 11776606 — intervention group
Group type: COMPARATOR
Intervention: Kytril
Number of subjects: 98
Study 11776606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasea and Kytril
Number of subjects: 98
Study 8874334 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 30 mg/d for 2 years plus 6 months of intravenous chemotherapy with cyclophosphamide, methotrexate, and fluorouracil (CMF)
Number of subjects: 705
Study 8874334 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen 30 mg/d for 2 years
Number of subjects: 705
Study 1353510 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine detergent shower
Number of subjects: 3482
Study 1353510 — intervention group
Group type: COMPARATOR
Intervention: Placebo detergent shower
Number of subjects: 3482
Study 6538013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alcohol administration
Number of subjects: 15
Study 6538013 — intervention group
Group type: COMPARATOR
Intervention: Propranolol therapy
Number of subjects: 15
Study 30517889 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CPAP treatment for 12 weeks
Number of subjects: 210
Study 30517889 — intervention group
Group type: COMPARATOR
Intervention: Sham-CPAP (sub‐therapeutic) device for 12 weeks
Number of subjects: 210
Study 30517889 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CPAP treatment
Number of subjects: 210
Study 29506208 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair-based pedal exercises (5 min three times a day with minimal supervision)
Number of subjects: 50
Study 29506208 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study 26358717 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 44
Study 26358717 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 44
Study 25142121 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartNetCare‐HF™ (HNC)
Number of subjects: 715
Study 22381532 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 160
Study 22381532 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic endoscopic imaging (MEI) colonoscope
Number of subjects: 160
Study 20616687 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 75 microg
Number of subjects: 60
Study 20616687 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 125 microg
Number of subjects: 60
Study 20616687 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 175 microg
Number of subjects: 60
Study 20616687 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 125 microg (repeated up to 3 times)
Number of subjects: 60
Study 20616687 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 60
Study 17532829 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal budesonide
Number of subjects: 4
Study 17532829 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral montelukast
Number of subjects: 4
Study 17532829 — intervention group
Group type: COMPARATOR
Intervention: Loratadine
Number of subjects: 4
Study 17532829 — intervention group
Group type: COMPARATOR
Intervention: Nasal sodium cromoglycate
Number of subjects: 4
Study 15580472 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapeutic pelvic floor training (CT)
Number of subjects: 60
Study 15580472 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CT with transanal electrical stimulation
Number of subjects: 60
Study 15580472 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CT with perineal electrical stimulation
Number of subjects: 60
Study 11994056 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (5 mg)
Number of subjects: 6
Study 11994056 — intervention group
Group type: COMPARATOR
Intervention: Intravenous midazolam (5 mg)
Number of subjects: 6
Study 10440916 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 875
Study 10440916 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 875
Study 7561442 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus urinaria
Number of subjects: 123
Study 7561442 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus amarus
Number of subjects: 123
Study 7561442 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus niruri
Number of subjects: 123
Study 7561442 — intervention group
Group type: COMPARATOR
Intervention: Control (no herbal therapy)
Number of subjects: 123
Study 2161633 — intervention group
Group type: COMPARATOR
Intervention: Thoracic radiotherapy alone (60 Gy over 6 weeks)
Number of subjects: 319
Study 2161633 — intervention group
Group type: COMPARATOR
Intervention: Thoracic radiotherapy plus vindesine (3 mg/m2 weekly for 6 weeks)
Number of subjects: 319
Study 2161633 — intervention group
Group type: COMPARATOR
Intervention: Vindesine alone (3 mg/m2 weekly for 6 weeks)
Number of subjects: 319
Study 498825 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 2.5 mg
Number of subjects: 0
Study 498825 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine 25 mg
Number of subjects: 0
Study 31267360 — intervention group
Group type: COMPARATOR
Intervention: Circulating NK cells in diffuse/mixed-type AGC (n=27)
Number of subjects: 67
Study 31267360 — intervention group
Group type: COMPARATOR
Intervention: Circulating Tregs in diffuse/mixed-type AGC (n=27)
Number of subjects: 67
Study 31267360 — intervention group
Group type: COMPARATOR
Intervention: CD8+ TILs in diffuse/mixed-type AGC (n=27)
Number of subjects: 67
Study 31267360 — intervention group
Group type: EXPERIMENTAL
Intervention: High circulating NK cell counts (>17%)
Number of subjects: 67
Study 31267360 — intervention group
Group type: EXPERIMENTAL
Intervention: High CD8+ TIL counts (>31 cells/field)
Number of subjects: 67
Study 31267360 — intervention group
Group type: EXPERIMENTAL
Intervention: CD8+ TILs after adjustment for confounding factors
Number of subjects: 67
Study 30991718 — intervention group
Group type: EXPERIMENTAL
Intervention: Chokeberry juice with high-dose polyphenols (1177.11 mg GAE)
Number of subjects: 100
Study 30991718 — intervention group
Group type: EXPERIMENTAL
Intervention: Chokeberry juice with low-dose polyphenols (294.28 mg GAE)
Number of subjects: 100
Study 30991718 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (polyphenol-free)
Number of subjects: 100
Study 30991718 — intervention group
Group type: EXPERIMENTAL
Intervention: Chokeberry juice (both doses)
Number of subjects: 100
Study 28532539 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel combined with platinum chemotherapy
Number of subjects: 81
Study 25592197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 218
Study 25592197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 23727257 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m2 IV Q3 weeks)
Number of subjects: 29
Study 23727257 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel + Vandetanib (100 mg PO daily)
Number of subjects: 29
Study 23727257 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 29
Study 21368320 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 55
Study 21368320 — intervention group
Group type: COMPARATOR
Intervention: Control (non-AT group)
Number of subjects: 55
Study 19389877 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 0
Study 19389877 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 120 mg
Number of subjects: 0
Study 19389877 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 240 mg
Number of subjects: 0
Study 19389877 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 0
Study 19389877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17498486 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Astragalus injection with cyclophosphamide (CTX)
Number of subjects: 43
Study 17498486 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CTX) alone
Number of subjects: 43
Study 15483371 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.65 g alcohol/kg body weight)
Number of subjects: 48
Study 15483371 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 48
Study 15483371 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 18044996 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-wise shockwave lithotripsy (SWL) with gradually increased output voltage (11, 12, and 13 kV)
Number of subjects: 50
Study 18044996 — intervention group
Group type: COMPARATOR
Intervention: Conventional shockwave lithotripsy (SWL) at 13 kV
Number of subjects: 50
Study 10926792 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombocytosis (platelet count >400 x 10(9)/liter)
Number of subjects: 291
Study 10926792 — intervention group
Group type: COMPARATOR
Intervention: No thrombocytosis
Number of subjects: 291
Study 8767986 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic vent
Number of subjects: 30
Study 8767986 — intervention group
Group type: COMPARATOR
Intervention: Conventional intercostal tube drainage
Number of subjects: 30
Study 1929035 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 42
Study 1929035 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin plus rifampin
Number of subjects: 42
Study 1929035 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 42
Study 7059752 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress (random shock)
Number of subjects: 0
Study 7059752 — intervention group
Group type: COMPARATOR
Intervention: Non-stress conditions
Number of subjects: 0
Study 31298571 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser (980 nm) enucleation of the prostate (DiLEP)
Number of subjects: 126
Study 31298571 — intervention group
Group type: COMPARATOR
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 126
Study 29807060 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia-ceramic FDPs (ZC)
Number of subjects: 58
Study 29807060 — intervention group
Group type: COMPARATOR
Intervention: Metal-ceramic FDPs (MC)
Number of subjects: 58
Study 29807060 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ZC and MC FDPs
Number of subjects: 58
Study 27736846 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel treatment
Number of subjects: 188
Study 27736846 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C8*3 carriers
Number of subjects: 188
Study 27736846 — intervention group
Group type: EXPERIMENTAL
Intervention: FGD4 c.2044‐236 A‐allele carriers
Number of subjects: 188
Study 25290151 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin 8% patch
Number of subjects: 46
Study 25290151 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 46
Study 22845420 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazoxide
Number of subjects: 16
Study 22845420 — intervention group
Group type: COMPARATOR
Intervention: Control (no diazoxide)
Number of subjects: 16
Study 20236342 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 346
Study 20236342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study 17635371 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha-2a, 180 microg once weekly
Number of subjects: 22
Study 17635371 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alpha-2b, 1.0 microg/kg once weekly
Number of subjects: 22
Study 16079391 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training and supported employment (CT + SE)
Number of subjects: 44
Study 16079391 — intervention group
Group type: COMPARATOR
Intervention: Supported employment only (SE Only)
Number of subjects: 44
Study 12106717 — intervention group
Group type: EXPERIMENTAL
Intervention: AR40e intraocular lens (IOL)
Number of subjects: 53
Study 12106717 — intervention group
Group type: COMPARATOR
Intervention: AR40 intraocular lens (IOL)
Number of subjects: 53
Study 12106717 — intervention group
Group type: COMPARATOR
Intervention: AR40 IOL
Number of subjects: 53
Study 10094741 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic tension-free inguinal hernia repair
Number of subjects: 64
Study 10094741 — intervention group
Group type: COMPARATOR
Intervention: Open tension-free inguinal hernia repair
Number of subjects: 64
Study 7828129 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy alone (RT)
Number of subjects: 185
Study 7828129 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy and surgery (RS)
Number of subjects: 185
Study 2156883 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (60% carbohydrate and 25% fat)
Number of subjects: 16
Study 2156883 — intervention group
Group type: COMPARATOR
Intervention: High fat diet (50% fat and 35% carbohydrate)
Number of subjects: 16
Study 2156883 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet
Number of subjects: 16
Study 2156883 — intervention group
Group type: COMPARATOR
Intervention: High fat diet
Number of subjects: 16
Study 31464923 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Care and Rehabilitation Program (CCRP)
Number of subjects: 240
Study 31464923 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study 29984258 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 60
Study 29984258 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 60
Study 28445888 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammatory stress (typhoid vaccination)
Number of subjects: 39
Study 28445888 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial stress (Trier Social Stress Test [TSST])
Number of subjects: 39
Study 28445888 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of inflammatory and psychosocial stress
Number of subjects: 39
Study 28445888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 28445888 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 39
Study 24521180 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacists (inexperienced in medication review) after receiving 2-day training in medication review
Number of subjects: 155
Study 24521180 — intervention group
Group type: COMPARATOR
Intervention: Expert reviewers
Number of subjects: 155
Study 22204993 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin
Number of subjects: 16
Study 22204993 — intervention group
Group type: COMPARATOR
Intervention: Gabexate mesilate
Number of subjects: 16
Study 20181387 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl followed by 17% EDTA
Number of subjects: 0
Study 20181387 — intervention group
Group type: COMPARATOR
Intervention: 1.3% NaOCl followed by 17% EDTA
Number of subjects: 0
Study 20181387 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 0
Study 20181387 — intervention group
Group type: COMPARATOR
Intervention: 1.3% NaOCl
Number of subjects: 0
Study 17034812 — intervention group
Group type: EXPERIMENTAL
Intervention: Context training (words presented in stories)
Number of subjects: 0
Study 17034812 — intervention group
Group type: COMPARATOR
Intervention: Isolated word training (words presented on flashcards)
Number of subjects: 0
Study 17034812 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer task employed at test
Number of subjects: 0
Study 15811899 — intervention group
Group type: EXPERIMENTAL
Intervention: medicines organizer (MO)
Number of subjects: 62
Study 15811899 — intervention group
Group type: COMPARATOR
Intervention: standard packaging
Number of subjects: 62
Study 12410941 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane
Number of subjects: 17
Study 12410941 — intervention group
Group type: COMPARATOR
Intervention: e‐PTFE membrane
Number of subjects: 17
Study 9608966 — intervention group
Group type: EXPERIMENTAL
Intervention: Trachlight lighted stylet
Number of subjects: 18
Study 9608966 — intervention group
Group type: EXPERIMENTAL
Intervention: Surch-Lite lighted stylet
Number of subjects: 18
Study 9608966 — intervention group
Group type: COMPARATOR
Intervention: Regular tracheal tube stylet
Number of subjects: 18
Study 9608966 — intervention group
Group type: EXPERIMENTAL
Intervention: All devices
Number of subjects: 18
Study 8579878 — intervention group
Group type: EXPERIMENTAL
Intervention: 120‐hour continuous infusion 5‐Fu and bolus cisplatin
Number of subjects: 36
Study 8579878 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 36
Study 2116667 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboembolism prophylaxis with heparin
Number of subjects: 303
Study 567007 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant protein diet (soy protein meat analogues and soy milk)
Number of subjects: 11
Study 567007 — intervention group
Group type: COMPARATOR
Intervention: Conventional diet containing mixed protein
Number of subjects: 11
Study 31017315 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper ministernotomy (M group)
Number of subjects: 100
Study 31017315 — intervention group
Group type: COMPARATOR
Intervention: Conventional sternotomy (C group)
Number of subjects: 100
Study 28873075 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion (30 mg/kg in the first hour followed by 9 mg/kg/h until the end of the surgical procedure)
Number of subjects: 294
Study 28873075 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 294
Study 28873075 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline at the same volume and rate)
Number of subjects: 294
Study 28873075 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 294
Study 25848773 — intervention group
Group type: EXPERIMENTAL
Intervention: rtfMRI neurofeedback (true feedback from rostral anterior cingulate cortex)
Number of subjects: 16
Study 25848773 — intervention group
Group type: COMPARATOR
Intervention: Sham neurofeedback (sham feedback from posterior cingulate cortex)
Number of subjects: 16
Study 23523255 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacutaneous Fibrolysis
Number of subjects: 120
Study 23523255 — intervention group
Group type: COMPARATOR
Intervention: Sham Diacutaneous Fibrolysis
Number of subjects: 120
Study 23523255 — intervention group
Group type: COMPARATOR
Intervention: Protocolised treatment (control)
Number of subjects: 120
Study 21241374 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 24
Study 21241374 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 24
Study 21241374 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 24
Study 18157018 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (5.7±0.2 mg/kg/h)
Number of subjects: 30
Study 18157018 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 30
Study 15988813 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 54
Study 15988813 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 54
Study 12406823 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 1,000 microg/day
Number of subjects: 244
Study 12406823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 12406823 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 244
Study 10333200 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (3 x 1 mg oral pH‐modified release)
Number of subjects: 83
Study 10333200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 10333200 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 83
Study 7475656 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG (coronary artery bypass grafting)
Number of subjects: 1054
Study 7475656 — intervention group
Group type: COMPARATOR
Intervention: PTCA (percutaneous transluminal coronary angioplasty)
Number of subjects: 1054
Study 7475656 — intervention group
Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 1054
Study 7475656 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1054
Study 1939676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 25
Study 1939676 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy (Control)
Number of subjects: 25
Study 7230083 — intervention group
Group type: EXPERIMENTAL
Intervention: Named stimulus pretraining condition
Number of subjects: 0
Study 7230083 — intervention group
Group type: COMPARATOR
Intervention: Unnamed stimulus pretraining condition
Number of subjects: 0
Study 7230083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dactylo-kinesthetic (fingerspelled) stimulus pretraining condition
Number of subjects: 0
Study 29020689 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpancreatic precut papillotomy (TPPP)
Number of subjects: 68
Study 29020689 — intervention group
Group type: COMPARATOR
Intervention: Double-guidewire technique (DGT)
Number of subjects: 68
Study 29020689 — intervention group
Group type: COMPARATOR
Intervention: Both TPPP and DGT
Number of subjects: 68
Study 28575774 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-based psychosocial group intervention (6 weekly 2-hour sessions)
Number of subjects: 83